Aidan Crawley

Aidan Crawley is the Co-Founder and CEO of Amber Therapeutics, a company focused on developing bioelectrical therapies for patients with peripheral nervous system disorders. Before their current role, Aidan was a Founder of Utter, a company addressing mental health issues related to emotional isolation. Aidan also held various positions in companies such as Masomo, Addepar, and Goldman Sachs, and has a background in financial analysis and business development. Aidan's educational background includes a BA in English Literature from Brasenose College, Oxford.